Bell Rock Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Bell Rock Capital's PFE Position: Q3 2022 in Review
Bell Rock Capital opened a new position in Pfizer (PFE) in Q3 2022: 5,445 shares worth $238K. The stake represents 0.29% of the portfolio and ranks #78 among its holdings. This is a return to the name: Bell Rock Capital previously reported a position in PFE as recently as Q1 2022.
Bell Rock Capital first reported a position in PFE in Q4 2016 and has held it in 16 quarters since. The position peaked at $1.26M in Q2 2017. 3,085 funds tracked by Wall St. Rank hold PFE as of Q3 2022.
- Bell Rock Capital held 5,445 shares of Pfizer worth $238K as of Q3 2022.
- Pfizer was a new Bell Rock Capital position in Q3 2022.
- Pfizer made up 0.29% of Bell Rock Capital's portfolio in Q3 2022, its #78 holding.
- Bell Rock Capital first reported a position in Pfizer in Q4 2016 and has held it in 16 quarters since.
- Bell Rock Capital's Pfizer position peaked at $1.26M in Q2 2017.
- 3,085 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.
Based on Bell Rock Capital's 13F filing for Q3 2022, filed 28 Oct 2022.